NASDAQ:ABCL

Abcellera Biologics Stock Insider Trading

Healthcare > Biotechnology

Buy ABCL

*Your capital is at risk

$5.72

-0.410 (-6.69%)

At Close: Jun 03, 2026

AbCellera Biologics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 30.8M and sold 1.22M ABCL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	30.8M shares
● Sell	1.22M shares
95% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Jan 02, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 100. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (95% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 06, 2025 Buy	Common Shares P-Purchase	Montalbano John S. Director	Director	60 000 Value: $140.6K
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Lecault Veronique Chief Operating Officer	C-Suite Officer	832 033 Value: $2.44M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Stimart Tryn Chief Legal Officer	Officer	832 033 Value: $2.44M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Booth Andrew Chief Financial Officer	C-Suite Officer	1 352 054 Value: $3.96M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Hansen Carl L. G. Chief Executive Officer	CEO / President	2 730 109 Value: $8.00M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Hansen Carl L. G. Chief Executive Officer	CEO / President	2 730 109 Value: $8.00M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Booth Andrew Chief Financial Officer	C-Suite Officer	1 352 054 Value: $3.96M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Lecault Veronique Chief Operating Officer	C-Suite Officer	832 033 Value: $2.44M
Jan 01, 2025 Buy	Share option (right to buy) A-Award	Stimart Tryn Chief Legal Officer	Officer	832 033 Value: $2.44M
Dec 04, 2024 Sell	Common Shares G-Gift	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	286 000 Value: $0
Dec 04, 2024 Sell	Common Shares G-Gift	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	286 000 Value: $0
Nov 25, 2024 Buy	Share option (right to buy) M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Nov 25, 2024 Buy	Common Shares M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Nov 25, 2024 Buy	Common Shares M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Nov 25, 2024 Buy	Share option (right to buy) M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Sep 20, 2024 Buy	Share option (right to buy) M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Sep 20, 2024 Buy	Common Shares M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Sep 20, 2024 Buy	Common Shares M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Sep 20, 2024 Buy	Share option (right to buy) M-Exempt	Hansen Carl L. G. Chief Executive Officer	CEO / President	56 125 Value: $151.5K
Aug 29, 2024 Buy	Common Shares P-Purchase	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	283 516 Value: $740.0K
Aug 29, 2024 Buy	Common Shares P-Purchase	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	283 516 Value: $740.0K
Jun 21, 2024 Buy	Share option (right to buy) A-Award	Lo Andrew Director	Director	163 934 Value: $482.0K
Jun 21, 2024 Buy	Share option (right to buy) M-Exempt	Lecault Veronique Chief Operating Officer	C-Suite Officer	83 334 Value: $15.7K
Jun 21, 2024 Buy	Share option (right to buy) A-Award	Montalbano John S. Director	Director	163 934 Value: $482.0K
Jun 21, 2024 Buy	Share option (right to buy) M-Exempt	Lecault Veronique Chief Operating Officer	C-Suite Officer	83 334 Value: $15.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABCELLERA BIOLOGICS INC.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and...

Read Full Profile Here